
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Recipient : SATT Conectus
Deal Size : Undisclosed
Deal Type : Licensing Agreement
SpikImm and SATT Conectus Sign a Agreement for Prophylactic Treatment Against the BK Virus
Details : Under the agreement, SpikImm gains worldwide exclusive licensing agreement for potent monoclonal antibodies targeting the BK virus.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
June 12, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Recipient : SATT Conectus
Deal Size : Undisclosed
Deal Type : Licensing Agreement

Contact Us!